Vascular Endothelial Growth Factor-B Acts as a Coronary Growth Factor in Transgenic Rats Without Inducing Angiogenesis, Vascular Leak, or Inflammation




Bry M, Kivela R, Holopainen T, Anisimov A, Tammela T, Soronen J, Silvola J, Saraste A, Jeltsch M, Korpisalo P, Carmeliet P, Lemstrom KB, Shibuya M, Yla-Herttuala S, Alhonen L, Mervaala E, Andersson LC, Knuuti J, Alitalo K

PublisherLIPPINCOTT WILLIAMS & WILKINS

2010

Circulation

CIRCULATION

CIRCULATION

17

122

17

1725

1733

9

0009-7322

DOIhttps://doi.org/10.1161/CIRCULATIONAHA.110.957332



Conclusions-VEGF-B appears to be a coronary growth factor in rats but not in mice. The signals for the VEGF-B-induced cardiac hypertrophy are mediated at least in part via the endothelium. Because cardiomyocyte damage in myocardial ischemia begins in the subendocardial myocardium, the VEGF-B-induced increased arterial supply to this area could have therapeutic potential in ischemic heart disease. (Circulation. 2010;122:1725-1733.)



Last updated on 2024-26-11 at 15:09